The Evolution of Long-Acting Antipsychotics Use in Québec between 2003 and 2017.
作者信息
Roy Marc-André
机构信息
Faculté de médecine, Université Laval, Québec, Québec, Canada.
Clinique Notre-Dame des Victoires, Institut Universitaire en Santé Mentale de Québec, CIUSSS Capitale-Nationale, Québec, Québec, Canada.
出版信息
Can J Psychiatry. 2020 Jul;65(7):510-511. doi: 10.1177/0706743720901975. Epub 2020 Feb 7.
Abstract
摘要
相似文献
1
The Evolution of Long-Acting Antipsychotics Use in Québec between 2003 and 2017.2003年至2017年间魁北克长效抗精神病药物的使用演变
Can J Psychiatry. 2020 Jul;65(7):510-511. doi: 10.1177/0706743720901975. Epub 2020 Feb 7.
2
Long-acting injectable antipsychotics in early psychosis: a literature review.长效注射抗精神病药在早期精神病中的应用：文献综述。
Early Interv Psychiatry. 2013 Aug;7(3):247-54. doi: 10.1111/eip.12027. Epub 2013 Jan 24.
3
Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?长效注射用抗精神病药：它们在治疗计划中的位置如何？
J Clin Psychiatry. 2018 Jan/Feb;79(1). doi: 10.4088/JCP.AL17017WC1C.
4
Use of two long-acting injectable antipsychotics for treatment-resistant schizophrenia.
Aust N Z J Psychiatry. 2018 Nov;52(11):1098-1099. doi: 10.1177/0004867418804059. Epub 2018 Oct 8.
5
Long-acting formulations of atypical antipsychotics: time to reconsider when to introduce depot antipsychotics.非典型抗精神病药物的长效制剂：是时候重新考虑何时引入长效抗精神病药物了。
CNS Drugs. 2007;21(6):441-8. doi: 10.2165/00023210-200721060-00001.
6
The importance of early and proactive use of long-acting injectable antipsychotics in the management of schizophrenia.
Int Clin Psychopharmacol. 2023 May 1;38(3):182-183. doi: 10.1097/YIC.0000000000000463. Epub 2023 Mar 6.
7
Long-acting injectable antipsychotics in the elderly: guidelines for effective use.老年患者长效注射用抗精神病药物：有效使用指南
Drugs Aging. 2003;20(15):1099-110. doi: 10.2165/00002512-200320150-00003.
8
Long-acting injectable antipsychotics: what, when, and how - CORRIGENDUM.
CNS Spectr. 2022 Dec;27(6):764. doi: 10.1017/S1092852921000778. Epub 2021 Sep 16.
9
Population pharmacokinetics and dosing of long-acting injectable antipsychotics.长效注射用抗精神病药物的群体药代动力学与给药剂量
J Psychiatry Neurosci. 2021 Sep 1;46(5):E516-E517. doi: 10.1503/jpn.210079.
10
Simulated long-term outcomes of early use of long-acting injectable antipsychotics in early schizophrenia.早期精神分裂症中长效注射抗精神病药物的早期使用的模拟长期结果。
Early Interv Psychiatry. 2019 Dec;13(6):1357-1365. doi: 10.1111/eip.12770. Epub 2018 Dec 9.
引用本文的文献
1
Long-Acting Injectable Antipsychotic Use in Children and Adolescents in Comparison to Adults.长效注射用抗精神病药物在儿童和青少年中的使用与成人的比较。
J Clin Med. 2025 Jul 17;14(14):5086. doi: 10.3390/jcm14145086.
本文引用的文献
1
[Long-acting antipsychotics: The QAAPAPLE algorithm review].[长效抗精神病药物：QAAPAPLE算法综述]
Can J Psychiatry. 2019 Oct;64(10):697-707. doi: 10.1177/0706743719847193. Epub 2019 May 14.
2
Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groups.2004年至2014年香港抗精神病药物的处方趋势及适应症：普通及弱势患者群体
Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1387-1394. doi: 10.1002/pds.4244. Epub 2017 Jun 30.
3
Antipsychotic long-acting injections: A community-based study from 2007 to 2014 of prescribing trends and characteristics associated with initiation.抗精神病长效注射剂：一项基于社区的2007年至2014年起始用药相关处方趋势及特征研究。
Schizophr Res. 2016 Dec;178(1-3):58-63. doi: 10.1016/j.schres.2016.09.014. Epub 2016 Sep 10.
4
Comparative effectiveness and safety of antipsychotic drugs in schizophrenia treatment: a real-world observational study.抗精神病药物治疗精神分裂症的比较疗效与安全性：一项真实世界观察性研究。
Acta Psychiatr Scand. 2016 Nov;134(5):374-384. doi: 10.1111/acps.12621. Epub 2016 Jul 12.
5
Trends in Off-Label Use of Second-Generation Antipsychotics in the Medicare Population From 2006 to 2012.2006年至2012年医疗保险人群中第二代抗精神病药物的非标签使用趋势
Psychiatr Serv. 2016 Aug 1;67(8):898-903. doi: 10.1176/appi.ps.201500316. Epub 2016 Apr 15.
6
Long-acting injectable antipsychotics: evidence of effectiveness and use.长效注射用抗精神病药：有效性和使用证据。
Can J Psychiatry. 2013 May;58(5 Suppl 1):5S-13S. doi: 10.1177/088740341305805s02.
7
Long-acting injectable antipsychotics: recommendations for clinicians.长效注射用抗精神病药物：临床医生的建议。
Can J Psychiatry. 2013 May;58(5 Suppl 1):30S-5S. doi: 10.1177/088740341305805s05.
8
[Long-acting injectable antipsychotics: an expert opinion from the Association des médecins psychiatres du Québec].[长效注射用抗精神病药物：魁北克精神科医生协会的专家意见]
Can J Psychiatry. 2011 Jun;56(6):367-76. doi: 10.1177/070674371105600608.
9
Medication decisions and clinical outcomes in the Canadian National Outcomes Measurement Study in Schizophrenia.
Acta Psychiatr Scand Suppl. 2006(430):12-21. doi: 10.1111/j.1600-0447.2006.00757.x.
Zotero 插件